Skip to Main Content

Author Details

Elena E Giorgi
2006
61
27
PMIDPaper TitleJournal TitlePublished Year
36787249Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults.2023
37628824Enhancement of Neutralization Responses through Sequential Immunization of Stable Env Trimers Based on Consensus Sequences from Select Time Points by Mimicking Natural Infection.2023
36629414A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.mBio2023
37384759Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.2023
37300931Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.EBioMedicine2023
35536018Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.Journal of Virology2022
35995954Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.Nature Medicine2022
35551291Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.Nature Medicine2022
34621054Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.Nature Medicine2021
33798244Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.PLoS Pathogens2021
34169114Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines.Molecular Therapy - Methods and Clinical Development2021
34337555Different evolutionary pathways of HIV-1 between fetus and mother perinatal transmission pairs indicate unique immune selection in fetuses.Cell Reports Medicine2021
32511348Emergence of SARS-CoV-2 through Recombination and Strong Purifying Selection.2020
32209678Estimating the Timing of Early Simian-Human Immunodeficiency Virus Infections: a Comparison between Poisson Fitter and BEAST.mBio2020
32493720Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials.mSphere2020
31415756HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.2019
31577800Association between mitochondrial genetic variation and breast cancer risk: The Multiethnic Cohort.PLoS One2019
29239895Development of broad neutralization activity in simian/human immunodeficiency virus-infected rhesus macaques after long-term infection.AIDS2018
30355496Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth.Cell Reports2018
30096313Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.Cell2018
29987026Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence.Proceedings of the National Academy of Sciences of the United States of America2018
29765018Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection.Nat Commun2018
29672607Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.PLoS Pathogens2018
28945784Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.PLoS Pathog2017
27909304Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences.Scientific Reports2016
27021046No Association between the Mitochondrial Genome and Prostate Cancer Risk: The Multiethnic Cohort.Cancer Epidemiol Biomarkers Prev2016
27434311Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.PLoS Pathog2016
26722117SPMM: estimating infection duration of multivariant HIV-1 infections.2016
26237403Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques.PLoS Pathogens2015
25540368A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.Journal of Virology2015
25855741Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.Journal of Virology2015
26468546Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification.J Virol2015
26506369Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants.Viruses2015
24965452Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer.Journal of Virology2014
24904019Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.Cancer Epidemiol Biomarkers Prev2014
25142591Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.J Virol2014
24837783Cross-reactive potential of human T-lymphocyte responses in HIV-1 infection.Vaccine2014
23542380Phenotypic properties of transmitted founder HIV-1.Proc Natl Acad Sci U S A2013
24243013Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.Cell2013
23567647Modeling sequence evolution in HIV-1 infection with recombination.Journal of Theoretical Biology2013
23221002Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains.Clinical and Vaccine Immunology2013
23004569A note on two-sample tests for comparing intra-individual genetic sequence diversity between populations.Biometrics2012
22927816Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing.PLoS Pathog2012
22065783Role of donor genital tract HIV-1 diversity in the transmission bottleneck.Proc Natl Acad Sci U S A2011
21307185Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection.J Virol2011
21379569Genital tract sequestration of SIV following acute infection.PLoS Pathogens2011
20485520High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.PLoS Pathogens2010
20808830Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.PLoS One2010
20973976Estimating time since infection in early homogeneous HIV-1 samples using a poisson model.BMC Bioinformatics2010
19414559Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.Journal of Experimental Medicine2009
  • 1 - 50 of 61

Recommended Authors

Collaborators

Co-authored papers 40
Co-authored papers 21
Co-authored papers 20
Co-authored papers 19
Co-authored papers 18
Co-authored papers 16
Co-authored papers 12
Co-authored papers 10
Co-authored papers 8
Co-authored papers 7
University of Southern California
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
University of Alabama at Birmingham
Co-authored papers 4
University of Southern California
Co-authored papers 4
Vitalant Research Institute
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Los Alamos National Laboratory
Co-authored papers 2
Co-authored papers 2
University of Minnesota Genomics Center (UMNGC)
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2